person

M. C.

Country
The Netherlands
Department
Gynaecology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 41 partner sites.

Specializations

Gynecologic Oncology

Focuses on malignant and premalignant conditions of the female reproductive tract, including vulvar high‑grade squamous intraepithelial lesion.

  • Adjuvant nonavalent HPV vaccination for vulvar HSIL
  • Surgical excision combined with immunoprophylaxis
  • Long‑term recurrence monitoring

Studies aim to reduce lesion progression and improve disease‑free outcomes.

Breast Cancer Therapeutics

Investigates targeted and endocrine strategies for triple negative breast cancer, HER2‑positive breast cancer, and HR+/HER2‑negative metastatic breast cancer.

  • Dual HER2 blockade with trastuzumab and pertuzumab
  • CDK4/6 inhibition combined with aromatase inhibitors
  • Immune checkpoint inhibition with pembrolizumab in residual disease

Emphasis on improving event‑free and overall survival across molecular subtypes.

Gastrointestinal Oncology

Addresses treatment optimization for locally advanced rectal cancer, gastric adenocarcinoma, and peritoneal dissemination of stomach tumors.

  • Preoperative chemotherapy regimens for resectable gastric cancer
  • Neoadjuvant chemoradiotherapy for rectal cancer
  • Cytoreductive surgery with HIPEC for peritoneal dissemination

Goal is to enhance resection rates and prolong survival.

Hematologic Oncology

Focuses on novel therapeutic sequences for multiple myeloma.

  • Induction with daratumumab‑lenalidomide‑dexamethasone followed by treatment‑free interval
  • Maintenance strategies post‑induction
  • Biomarker‑driven response assessment

Research seeks to balance disease control with quality of life.

Thrombosis Prophylaxis

Evaluates risk‑adapted prevention of venous thromboembolism in orthopedic surgery patients.

  • Individualized prophylaxis versus standard regimen
  • Assessment of bleeding complications
  • Stratification by low, intermediate, and high VTE risk

Findings aim to refine prophylactic guidelines.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.